Aims Review Committee – Joint Biology Consortium

Aims Review Committee (ARC) is a mentoring program specifically designed to enhance grantwriting skills and funding for JBC investigators at all levels who are in the process of grant submission. ARC maximizes the chance of success, with a funding rate for submitted grants approaching 60%.

When are they held?

ARC meetings occur every 1-2 months; please email jbc@bwh.harvard.edu to be added to the distribution list and learn about upcoming meetings.

Grants Funded

#	Year	Grant Type	Funder	Principal Investigator	Topic
1	2012	K08	NIH/NIAMS	Erika Noss, MD, PhD	Inflammatory arthritis
2	2012	K08	NIH/NIAMS	Julia Charles, MD, PhD	Inflammatory arthritis
3	2012	R21	NIH/NIAMS	Peter Nigrovic, MD	Inflammatory arthritis
4	2012		Scleroderma Foundation	Antonios O. Aliprantis MD, PhD	Scleroderma
5	2012	R01	NIH/NIAMS	Peter Nigrovic, MD	Neutrophil biology
6	2013	Pilot	RRF	Antonios O. Aliprantis MD, PhD	Inflammatory arthritis
7	2013	DTRG	RRF	Peter Nigrovic, MD	Inflammatory arthritis
8	2013	SDA	RRF	Pui Lee, MD, PhD	Monocyte biology
9	2013	R01	NIH/NIA	Antonios O. Aliprantis MD, PhD	Inflammatory arthritis
10	2014	SDA	RRF	Lauren Henderson, MD, MMSc	Inflammatory arthritis
11	2014	IIRG	Novartis	Peter Nigrovic, MD	Inflammatory arthritis
12	2014	IIRG	Pfizer	Yvonne Lee, MD, MPH	Inflammatory arthritis
13	2014	R01	NIH/NIAID	Tanya Laidlaw, MD	Aspirin-associated respiratory disease
14	2015	Pilot	RRF	Antonios O. Aliprantis MD, PhD	Inflammatory arthritis
15	2015		ANRF	Gang Li, PhD	Inflammatory arthritis
16	2015	K23	NIH/NIAMS	Jeffrey Sparks, MD, MMSc	Inflammatory arthritis
17	2015		Mallinckrodt	Deepak Rao, MD, PhD	Inflammatory arthritis
18	2015		Mallinckrodt	Kevin Wei, MD, PhD	Inflammatory arthritis
19	2016	P30	NIH/NIAMS	Peter Nigrovic, MD	Inflammatory arthritis
20	2016	CDA	Lupus Research Alliance	Sara Tedeschi, MD, MPH	Osteoporosis, SLE
21	2016	K23	NIH/NIAMS	Candace Feldman, MD, PhD	SLE
22	2016	IRA	RRF	Peter Nigrovic, MD	Inflammatory arthritis
23	2016		Faculty award, BWH	Julia Charles, MD, PhD	Bone biology
24	2017	P30	NIH/NIAMS	Daniel Solomon, MD, MPH	Rheumatology
25	2017	K08	NIH/NIAMS	Deepak Rao, MD, PhD	Inflammatory arthritis
26	2017	K08	NIH/NIAMS	Lauren Henderson, MD, MMSc	Inflammatory arthritis
27	2018		ANRF	A. Helena Jonsson, MD, PhD	Inflammatory arthritis
28	2018		ANRF	Pierre Cunin, PhD	Inflammatory arthritis
29	2018	K12	NIH/NIAMS	Kevin Wei, MD, PhD	Inflammatory arthritis
30	2018	R01	NIH/NIAMS	Peter Nigrovic, MD	Inflammatory arthritis
31	2019	K08	NIH/NIAMS	Pui Lee, MD, PhD	Monocyte biology
32	2019	K23	NIH/NIAMS	Sara Tedeschi, MD, MPH	Pseudogout
33	2019	SDA	RRF	Lindsey MacFarlane, MD	Osteoarthritis
34	2019	IA	RRF	Paul Hoover, MD, PhD	SLE
35	2019	R01	NIH/NIAMS	Peter Nigrovic, MD	Neutrophil biology
36	2019		ANRF	A. Helena Jonsson, MD, PhD	Inflammatory arthritis
37	2019		ANRF	Christian Jacome-Galarza, PhD	Osteoclasts
38	2019	K08	NIH/NIAMS	Kevin Wei, MD, PhD	Inflammatory arthritis
39	2019		ANRF	Pierre Cunin, PharmD, PhD	Inflammatory arthritis
40	2019	K08	NIH/NIAMS	Damien Simmons, MD, PhD	Inflammatory arthritis
41	2019	IA	RRF	A. Helena Jonsson, MD, PhD	Inflammatory arthritis
42	2020	R21	NIH/NIAMS	Peter Nigrovic, MD	Megakaryocytes
43	2020	K23	NIH/NIAMS	Kazuki Yoshida, MD	Gout
44	2020	K12	NIH	Margaret Chang, MD, PhD	Inflammatory arthritis
45	2020		Boehringer-Ingelheim	Felix Radtke	Neutrophils
46	2020	R21	NIH	Julia Charles, MD, PhD	Osteoclasts
47	2020	R01	NIH/NIAMS	Deepak Rao, MD, PhD	Inflammatory arthritis
48	2020	IRA	RRF	Kevin Wei, MD, PhD	Inflammatory arthritis
49	2020	SDA	RRF	Kiki Cunningham, MD, PhD	Checkpoint inhibitors
50	2020	SDA	RRF	Alisa Mueller, MD, PhD	Inflammatory arthritis
51	2020		Hood	Pui Lee, MD, PhD	Juvenile Idiopathic Arthritis
52	2020		Gilead	Maria Gutierrez-Arcelus, PhD	SLE